ResearcherGarvan Institute of Medical ResearchActive in the last 2 years
Tanya M. Dwarte
Matched on ORCID iD 0000-0003-0918-7820; OpenAlex author ID A5008322025. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2019: 2 papers · 2020: none · 2021: 3 papers · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 8
- Five-year psychological impact and surveillance compliance in the Australian Pancreatic Cancer Screening Program. Co-author DOI 10.1007/s10689-026-00557-0↗
- A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer. Co-author DOI 10.1038/s43018-023-00614-y↗
- Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence. Co-author DOI 10.1053/j.gastro.2021.09.022↗
- ROR1 and ROR2 expression in pancreatic cancer. Co-author DOI 10.1186/s12885-021-08952-9↗
- Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants. First author DOI 10.1186/s13053-021-00190-1↗
- Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants First author DOI 10.1186/s13053-021-00195-w↗
- CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan. Co-author DOI 10.1038/s41467-019-10968-6↗
- Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program. Co-author DOI 10.1186/s13053-019-0129-1↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Alina Stoita · 4 shared papers, 2019–2026 · strength 0.69
- Paper Five-year psychological impact and surveillance compliance in the Australian Pancreatic Cancer Screening Program. DOI 10.1007/s10689-026-00557-0↗
- Paper Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participant… DOI 10.1186/s13053-021-00190-1↗
- Paper Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Prog… DOI 10.1186/s13053-021-00195-w↗
- Anthony James Gill · 1 shared paper, 2026 · strength 0.36
- Amber L. Johns · 3 shared papers, 2019–2021 · strength 0.33
- Paper Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participant… DOI 10.1186/s13053-021-00190-1↗
- Paper Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Prog… DOI 10.1186/s13053-021-00195-w↗
- Paper Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program. DOI 10.1186/s13053-019-0129-1↗
- Krithika Murali · 2 shared papers, 2021 · strength 0.23
- Paper Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participant… DOI 10.1186/s13053-021-00190-1↗
- Paper Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Prog… DOI 10.1186/s13053-021-00195-w↗
- Marios Efthymiou · 2 shared papers, 2021 · strength 0.23
- Paper Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participant… DOI 10.1186/s13053-021-00190-1↗
- Paper Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Prog… DOI 10.1186/s13053-021-00195-w↗
- Mehrdad Nikfarjam · 2 shared papers, 2021 · strength 0.23
- Paper Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participant… DOI 10.1186/s13053-021-00190-1↗
- Paper Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Prog… DOI 10.1186/s13053-021-00195-w↗
- Rhys Vaughan · 2 shared papers, 2021 · strength 0.23
- Paper Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participant… DOI 10.1186/s13053-021-00190-1↗
- Paper Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Prog… DOI 10.1186/s13053-021-00195-w↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.